Cite
HARVARD Citation
Rugo, H. et al. (n.d.). Predictors of efficacy in patients (pts) with hormone receptor–positive/ human epidermal growth factor receptor 2–negative advanced breast cancer (HR+/HER2− ABC): Subgroup analyses of PALOMA-3. European journal of cancer. pp. S7-S8. [Online].